Key points are not available for this paper at this time.
Endocervical Adenocarcinoma (EAC) is the second most prevalent malignancy of the uterine cervix, with a significant portion linked to high-risk HPV infection 1. The incidence of EAC has risen notably, now accounting for up to 25% of new cervical cancer diagnoses at 1.44/100,000 women in the United States 2. Overall survival is mainly related to the FIGO (International Federation of Gynecology and Obstetrics) stage with decreased survival in advanced staging.
Wang et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: